Studies on effect of carcinoembryonic antigen on leucocyte migration inhibition test in patients with colorectal cancer.
Gastroenterol Jpn
; 18(5): 440-4, 1983 Oct.
Article
em En
| MEDLINE
| ID: mdl-6653990
ABSTRACT
Leucocyte migration inhibition test (LMIT) is a useful method to detect tumor associated antigens (TAA) in cancer patients. Carcinoembryonic antigen (CEA) is one of the best tumor markers for gastrointestinal cancer, and especially for colorectal cancer patients, who show high plasma CEA level frequently. In this study, we performed LMIT in 71 colorectal cancer patients with 3 M KCl extracts of cancer tissues and measured concentration of CEA in the plasma and the extracts of cancer tissue simultaneously. Although CEA in colorectal cancer extracts was individually varied from low to high in concentration, the levels of CEA had no relation to LMI reactivity. In addition, the LMI reactivity of colorectal cancer patients did not relate to the plasma CEA level of the corresponding patient. The results suggest that some antigens which induce leucocyte migration inhibition factor (LMIF) to lymphocytes from colorectal cancer patients might be different substances from CEA.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Retais
/
Inibição de Migração Celular
/
Antígeno Carcinoembrionário
/
Neoplasias do Colo
/
Leucócitos
Limite:
Humans
Idioma:
En
Revista:
Gastroenterol Jpn
Ano de publicação:
1983
Tipo de documento:
Article